Argonaute 2 expression correlates with a Luminal B breast cancer subtype and induces estrogen receptor alpha isoform variation

Adrienne K. Conger, Elizabeth C. Martin, Thomas J. Yan, Lyndsay V. Rhodes, Van T. Hoang, Jacqueline La, Muralidharan Anbalagan, Hope E. Burks, Brian G. Rowan, Kenneth P. Nephew, Bridgette M. Collins-Burow, Matthew E. Burow

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Estrogen receptor alpha (ERα) signaling pathways are frequently disrupted in breast cancer and contribute to disease progression. ERα signaling is multifaceted and many ERα regulators have been identified including transcription factors and growth factor pathways. More recently, microRNAs (miRNAs) are shown to deregulate ERα activity in breast carcinomas, with alterations in both ERα and miRNA expression correlating to cancer progression. In this study, we show that a high expression of Argonaute 2 (AGO2), a translation regulatory protein and mediator of miRNA function, correlates with the luminal B breast cancer subtype. We further demonstrate that a high expression of AGO2 in ERα+ tumors correlates with a poor clinical outcome. MCF-7 breast cancer cells overexpressing AGO2 (MCF7-AGO2) altered ERα downstream signaling and selective ERα variant expression. Enhanced ERα-36, a 36 kDa ERα isoform, protein and gene expression was observed in vitro. Through quantitative polymerase chain reaction (qPCR), we demonstrate decreased basal expression of the full-length ERα and progesterone receptor genes, in addition to loss of estrogen stimulated gene expression in vitro. Despite the loss, MCF-7-AGO2 cells demonstrated increased estrogen stimulated tumorigenesis in vivo. Together with our clinical findings on AGO2 expression and the luminal B subtype, we suggest that AGO2 is a regulator of altered ERα signaling in breast tumors.

Original languageEnglish (US)
Article number8
JournalNon-coding RNA
Volume2
Issue number3
DOIs
StatePublished - Sep 21 2016

Keywords

  • AGO2
  • Estrogen receptor
  • Isoform
  • Luminal B
  • MiRNA

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'Argonaute 2 expression correlates with a Luminal B breast cancer subtype and induces estrogen receptor alpha isoform variation'. Together they form a unique fingerprint.

  • Cite this

    Conger, A. K., Martin, E. C., Yan, T. J., Rhodes, L. V., Hoang, V. T., La, J., Anbalagan, M., Burks, H. E., Rowan, B. G., Nephew, K. P., Collins-Burow, B. M., & Burow, M. E. (2016). Argonaute 2 expression correlates with a Luminal B breast cancer subtype and induces estrogen receptor alpha isoform variation. Non-coding RNA, 2(3), [8]. https://doi.org/10.3390/ncrna2030008